⌘K

Home/Filings/4/0001213900-23-003547

4//SEC Filing

David Matthew T 4

Accession 0001213900-23-003547

CIK 0001410098other

View on SEC.gov Company Profile

Filed

Jan 17, 7:00 PM ET

Accepted

Jan 18, 6:53 PM ET

Size

6.1 KB

Accession

0001213900-23-003547

Insider Transaction Report

Form 4

Period: 2023-01-14

CorMedix Inc.CRMD

David Matthew T

Chief Financial Officer

Transactions

Award
Stock Option (Right to Buy Common Stock)
2023-01-14+125,000→ 125,000 total
Exercise: $4.43Exp: 2033-01-14→ Common Stock (125,000 underlying)

Holdings

Common Stock
3,150

Footnotes (1)

[F1]These options were granted on 1/14/2023. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

Documents

1 file

4
ownership.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

CorMedix Inc.

CIK 0001410098

Entity typeother

Related Parties

1

filerCIK 0001811612

Filing Metadata

Form type: 4
Filed: Jan 17, 7:00 PM ET
Accepted: Jan 18, 6:53 PM ET
Size: 6.1 KB

View on SEC.gov